Biotech Archives - Page 39 of 89 - Boston Life Sciences Times

Iterative Health Raises $77 Million to Expand Clinical Research Network

April 30, 2026

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

April 28, 2026

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

April 27, 2026

THIS WEEK'S STORIES

Motif Neurotech Wins FDA Clearance to Launch First Human Trial for Depression Implant

April 27, 2026

Premier Study Unveils New Tool to Identify High-Risk Pregnancies Earlier

April 27, 2026

Convergent Therapeutics Appoints Andrew Davis as Chief Business and Strategy Officer

April 29, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Biotech

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

Charles River Launches Rat IVF Services to Support Research Model Programs

VectorY Therapeutics Cleared to Expand ALS Clinical Trial to Europe and U.K.

Boston Cell Standards Advances Toward FDA Qualification for Cancer Testing Platform

Seaport Therapeutics Adds Biotech Leader Sharon Mates to Board

Most Read

Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board

SK Capital Completes Sale of Noramco Group Businesses to Siegfried

GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

EDITOR PICKS

Iterative Health Raises $77 Million to Expand Clinical Research Network

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

THIS WEEK'S STORIES

Motif Neurotech Wins FDA Clearance to Launch First Human Trial for Depression Implant

Premier Study Unveils New Tool to Identify High-Risk Pregnancies Earlier

Convergent Therapeutics Appoints Andrew Davis as Chief Business and Strategy Officer

POPULAR CATEGORY

ABOUT US

FOLLOW US